Search News
| 4.31 Delayed Data As of 4:00pm ET |  +0.03 / +0.70%Today’s Change | 3.33 Today|||52-Week Range 7.88 | +4.11% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Cooper Laurence James Neil Chief Executive Officer |  Sale | 5/05/2017 | 132,000 | $7.12 | $939.8K | -39.89% |
Belbel Caesar J | Sale | 12/30/2017 | 31,450 | $4.14 | $130.2K | -3.60% |
Lebel Francois /ziopharm/ Executive Vice President-Research & Development | Sale | 12/30/2017 | 31,450 | $4.14 | $130.2K | -3.60% |
Cooper Laurence James Neil Chief Executive Officer | Sale | 12/30/2017 | 26,178 | $4.14 | $108.4K | -3.60% |
Belbel Caesar J | Sale | 6/01/2017 | 16,666 | $6.11 | $101.8K | -29.95% |
Belbel Caesar J | Sale | 12/31/2017 | 21,667 | $4.14 | $89.7K | -3.60% |
Lebel Francois /ziopharm/ Executive Vice President-Research & Development | Sale | 12/31/2017 | 21,667 | $4.14 | $89.7K | -3.60% |
Fowler Wyche Jr Director | Sale | 6/12/2017 | 13,980 | $5.47 | $76.5K | -21.76% |
Weiser Michael Director | Sale | 6/12/2017 | 13,300 | $5.47 | $72.8K | -21.76% |
Brennan Murray F Director | Sale | 6/12/2017 | 13,300 | $5.47 | $72.8K | -21.76% |
